GlassScriptPhysician profile
Rimma Finkel
NPI 1134325152
$7,442.38
in general payments reported to CMS, 2019-2025
10 companies · $1,146 in 2025
The $1,146 reported for 2025 was more than what 76% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $564 · 2021: $719 · 2022: $2,688 · 2023: $929 · 2024: $878 · 2025: $1,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,952.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $2,908.05 | 2021-2025 | |
| Mentor Worldwide LLC | $1,901.31 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Tela Bio, INC. | $940.03 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Allergan, INC. | $898.48 | 2019-2022 | |
| Biocomposites INC | $194.56 | 2024 | |
| Sientra, INC. | $182.86 | 2022 | |
| Integra Lifesciences Corporation | $145.54 | 2023 | Durasorb Monofilament Mesh |
| Davol INC. | $136.63 | 2025 | Arista |
| Abbvie INC. | $68.60 | 2024 | |
| Mimedx Group, INC. | $66.32 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rimma Finkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.